SPIRONOLACTONE | A040750 | OXFORD PHARMACEUTICALS LLC
Highest NADAC/Unit
$0.1759
per ea
Lowest NADAC/Unit
$0.0443
per ea
Brand NDCs
0
Generic NDCs
10
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 69584085410SPIRONOLACTONE 100 MG TABLET | $0.1759 | EA | Generic | — | 2026-06-17 |
| 69584085490SPIRONOLACTONE 100 MG TABLET | $0.1759 | EA | Generic | — | 2026-06-17 |
| 69584085450SPIRONOLACTONE 100 MG TABLET | $0.1759 | EA | Generic | — | 2026-06-17 |
| 69584085350SPIRONOLACTONE 50 MG TABLET | $0.0875 | EA | Generic | — | 2026-06-17 |
| 69584085310SPIRONOLACTONE 50 MG TABLET | $0.0875 | EA | Generic | — | 2026-06-17 |
| 69584085390SPIRONOLACTONE 50 MG TABLET | $0.0875 | EA | Generic | — | 2026-06-17 |
Showing 6 of 10 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.